The monostrut Björk-Shiley heart valve  by Björk, Viking O. & Lindblom, Dan
1142 JACC Vol. 6. No.5 
November 1985:1142-8 
SEMINAR ON CARDIAC VALVE REPLACEMENT-II 
John H. K. Vogel, MD, FACC, Guest Editor 
The Monostrut Bjork-Shiley Heart Valve 
VIKING 0. BJORK, MD, HON FACC, DAN LINDBLOM, MD 
Stockholm. Sweden 
To avoid the possibility of a fracture of the welded two•
armed outflow strut of the Bjork-Shiley heart valve, since 
1982 it has been machined from one piece of Haynes 25 
in the form of a monostrut valve without welds. Of the 
first 864 patients with a monostrut Bjork-Shiley valve 
implanted, 268 have now been followed up to 3 years. 
The clinical findings, as well as absence of hemolysis, 
excellent hemodynamics even with a narrow aortic root 
The Bjork-Shiley mono strut heart valve was introduced in 
1982 in an attempt to completely eliminate mechanical dys•
function; 864 monostrut valves have been introduced during 
this 31/2 year period at the Karolinska Hospital. In this re•
port, the first 268 patients operated on with up to 3 years 
of follow-up evaluation are described. 
The Valve 
During 16 years of clinical experience with more than 
3,600 Bjork-Shiley tilting disc valves at the Karolinska Hos•
pital, a stepwise improvement has been made as long-term 
experience has been gained. The development has concen•
trated on improving: 1) durability, 2) hemodynamic func•
tion, and 3) the incidence of thromboembolic complications. 
Durability. To improve durability, the Delrin disc (l) 
was changed to a pyrolite carbon disc in 1971 (2). During 
10 years of use of the Bjork-Shiley valve without any me•
chanical failure, only one inflow strut fracture occurred after 
7 years among 1,476 valves (or 0.07% of valves) with a 
flat disc (3-5). In 1977, the inflow strut was then made an 
integral part of the valve ring and has never since caused 
any fracture (6,7). 
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as demonstrated by transseptal cardiac catheterization 
and excellent functional improvement are reported. No 
valve thrombosis in patients receiving anticoagulant 
therapy was observed with valves in either the aortic or 
the mitral position and there was no case of mechanical 
failure. 
(1 Am Coli CardioI1985;6:1142-8) 
When the convexo-concave disc was introduced, the out•
flow strut was welded into the flange at an angle and not 
parallel to the flange, as was the case with flat disc valves. 
This increased the stress at the strut-flange junction during 
both valve opening and valve closing, and caused an outflow 
strut fracture when the welds were not perfect; during a 6 
year period such fractures occurred in 5 (0.6%) of 860 valves 
with a 60° opening angle. Four of these fractures occurred 
in valves in the aortic position. When the opening angle 
was increased to the optimum of 70° (8), 10 fractures oc•
curred among 578 cases (1.7%) (9). Six of these fractures 
occurred within 6 months after operation, and five of these 
involved mitral valves ranging in size from 29 to 31 mm. 
Mitral valves of this size were, therefore, immediately aban•
doned after April 1982, and within 1 year all 70° valves 
were recalled by the manufacturer. This model had never 
been used in the United States. 
In 1982, therefore, the outflow strut was also made an 
integral part of the valve ring in the form of a monostrut. 
This avoided all welds so that now the entire valve is made 
from one piece of Haynes 25, a cobalt base alloy, cut from 
bar stock. The integral struts and ring are formed by an 
electrochemical machining process (Fig. 1A). The metal is 
then selectively removed (Fig. 1B), and the inlet and outlet 
struts are separated and trimmed using conventional ma•
chining methods (Fig. 1C). The valve is polished and the 
suture ring added (Fig. 10). The outflow mono strut contains 
1.75 times more metal than the two-armed outflow strut. It 
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Figure 1. Valve preparation by electrochemical machining. A, 
The monostrut orifice ring and integral struts are formed from one 
piece of Haynes 25. B, The metal is then selectively removed. C, 
The inlet and outlet struts are separated, trimmed and polished. 
D, The finished aortic Bjork-Shiley mono strut valve. 
has a uniform metal grain structure, The fatigue endurance 
limit of Haynes 25 is 4,900 kg/cm2; in a patient, this limit 
will never exceed 700 kg/cm2 on the outlet strut (Fig, 2), 
Because the greatest in-service load on the monostrut is 309 
g at a blood pressure of 200 mm Hg, there is a to-fold 
safety reserve (Fig, 3), The valve can be cycled at a rate 
of 600 per minute against an overpressure of I ,250 mm Hg 
(10), When other valves fracture, the monostrut does not. 
Four hundred million cycles, with a load of 5 kg on the 
outflow strut, corresponding to 10 years of service, will not 
cause any failure of the monostrut. Therefore, the monostrut 
valve cannot be fractured under extreme experimental con•
ditions and never under peak physiologic conditions, No 
mechanical failure has been encountered in the 864 mon•
ostrut valves machined from a single piece of Haynes 25 
without welds at the Karolinska Hospital during a 3 '12 year 
period, nor in I I ,700 cases elsewhere around the world, 
Hemodynamic function. The optimal hemodynamics 
of the tilting disc valve necessitated a convexo-concave disc 
shape that simulated an airplane wing, The convexo-
Figure 2. The fatigue endurance limit for Haynes 25 at IO million 
cycles of bending within its elasticity limit is 4,900 kg/cm2, The 
operating stress under peak physiologic loading conditions is 800 
kg/cm2 for the inlet strut and 700 kg/cm2 for the outlet strut. KSI 
= 1,000 Ib/in2• 
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Figure 3. The peak load on the outflow monostrut was 309 g 
during valve opening. 
concave disc opens fully for only half the flow as compared 
with a flat disc resulting in a 15% lower gradient. By in•
creasing the opening angle from 60 to 70°, the gradient 
diminishes further to 10% (Fig. 4). The 70° convexo-concave 
valve has a significantly improved flow characteristic be•
cause the turbulence and vortex formation impairing flow 
through the smaller hole disappear (Fig. 5) (II). There is 
no rationale for further increasing the opening angle because 
pulsative regurgitation increases in a linear fashion with an 
increase in the opening angle (8). Because the Bjork-Shiley 
tilting valve disc is not overlapping, hemolysis is minimal, 
with normal values of hemoglobin and reticulocytes and 
close to normal levels of serum lactic dehydrogenase. 
During surgery, the functional orientation of the valve 
is of primary importance so that the disc does not impinge 
and free movement is guaranteed. In contrast, the hemo•
dynamic orientation is only of secondary importance. If 
possible, however, in the aortic position, the large opening 
is oriented against the convexity of the ascending aorta, 
which means anterior and slightly to the right, usually against 
the commissure between the right and noncoronary cusps 
(Fig. 6) (8). In the mitral position, the large opening should 
be oriented away from the aortic orifice (Fig. 7 A); other-
Figure 4. The opening angle was increased from 60 to 70° in the 
monostrut valve. 
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Figure 5. hi the 70° monostrut valve turbulence and vortex for•
mation are diminished, improving the flow through the smaller 
hole (A) in comparison with the 60° convexo-concave valve (B) 
and the standard Bjork-Shiley valve with a flat disc (C). (A, used 
with permission from Reul H. Personal communication, 1985. B 
and C, reprinted with permission from Bruss KH, ct al. r II J.) 
wise, slight aortic regurgitation will delay closure and be 
directed into the left atrium by the disc (Fig. 7B). Further•
more, the upper portion of the interventricular septum will 
move inward during diastole, narrowing anterior but not 
posterior inflow (Fig. 7C), 
Thromboembolic complications. To diminish throm•
boembolic complications, the flat disc was changed to a 
convexo-concave disc (Fig, 8), The flat disc extended out 
to the ring in the fully open position, causing a low flow 
area behind the valve. At this point, thrombosis started when 
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Figure 6. For free movements of the disc to be obtained, the large 
opening of the aortic valve is oriented toward the convexity of the 
ascending aorta or anteriorly and slightly to the right. 
anticoagulation was not perfect. The convexo-concave disc 
permitted the disc to slide 2,5 mm from the ring, creating 
a space between the edge of the disc and the ring. This 
diminished the low flow areas (as measured by laser Doppler 
recording) by 50% and reduced thromboembolic compli•
cations significantly in the mitral area. Seven hundred sixty•
eight patients were separated into two groups with more 
than 350 patients in each group. In one group a convexo•
concave disc, either with the two-armed outflow strut or 
with the mono strut was used; in the other, a flat disc was 
used. The groups were comparable from the standpoint of 
clinical findings, concomitant tricuspid procedures, pre•
vious cardiac surgery and age. It was found that the in•
stantaneous rate of valve thrombosis was more pronounced 
during the first years after implantation, but very much lower 
when a convexo-concave disc was used (Fig. 9). Regarding 
the percent freedom of valve thrombosis, there was a sig•
nificant difference favoring use of a convexo-concave disc 
rather than a flat disc (Fig. 10). Additionally, in terms of 
the percent of valves free from all episodes of thromboem•
bolism, there was a significant difference between the con•
vexo-concave and the flat discs. The 7 year results showed 
a 9% better actuarial survival of patients with the convexo•
concave disc because there were significantly fewer throm•
boembolic complications (Fig. II). The mono strut valve 
naturally has one less arm, and of the 864 mono strut valves 
implanted at the Karolinska Hospital, 295 valves have been 
implanted for more than 2 years. Evaluation of the linear 
complications in this group of monostrut valves in patients 
receiving anticoagulant therapy reveals no valve thrombosis 
in any mitral or aortic valve. 
A 
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Figure 7. A, In the mitral position, the large opening should, if 
possible, be oriented away from the aortic orifice. B, Aortic re•
gurgitation will delay valve closure and cause mitral insufficiency 
if the large opening of the mitral valve is against the root of the 
aorta. C, The upper position of the septum moves inward during 
diastole (DIAST.). SYST. = systole. 
Patient Characteristics 
At operation, the average age of the 268 patients followed 
up for between 2 and 3 years was 60 years (range 2 to 78). 
Patient characteristics for aortic and mitral valve replace-
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Figure 8. The monostrut mitral valve in the open position with a 
space between the disc and the orifice. 
ments are summarized in Table 1. The locations of valve 
implantation are shown in Table 2. 
Results 
Mortality. The early (30 day) mortality rate was 4%. 
The 2 year actuarial survival rate, including this early 4% 
operative mortality rate, was 93% for isolated aortic valve 
replacement and 91 % for isolated mitral valve replacement. 
Complications. The incidence of bleeding complica•
tions was 13% per patient-year. Thromboembolic compli•
cations were most frequent during the first year after op•
eration, as is demonstrated in Figures 9 and 10. Therefore, 
a significant decrease is anticipated when more follow-up 
years are added to the series. The total thromboembolic 
complication rate was 0.6% per patient-year after aortic 
valve replacement and 2.6% per patient-year after mitral 
valve replacement in patients receiving anticoagulant ther•
apy. There was, however, not a single instance of valve 
thrombosis in either position (Table 3). 
Functional improvement. Before surgery, 62% of the 
patients were in New York Heart Association functional 
Figure 9. Instantaneous rate (%) of valve thrombosis postoper•
atively (POST-OP) after mitral valve replacement was more pro•
nounced during the first years, especially in patients with a flat 
disc (upper curve) as compared with the convexo-concave disc 
(lower curve) in patients with the two-armed outflow strut and 
the monostrut. Vertical bars = 70° confidence limit; : = p < 
om. 
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Figure 10. The convexo-concave disc (upper curve) demon•
strated a significantly higher percent of freedom of valve throm•
bosis than did the flat disc (lower curve). Two rows of numbers 
at bottom are patients at risk for convexo-concave disc (top) and 
flat disc (bottom). OP = operation; POST-OP = postoperative. 
class III or IV. Only 4% were in the same class 12 months 
after surgery, which represents a highly significant improve•
ment (Fig. 12). 
Hemolysis. The blood was studied in 125 patients 1 year 
after the valve operation. Hemoglobin and reticulocyte count 
Figure 11. The 7 year actuarial survival rate was 80% for mitral 
valve replacement (MVR) with the convexo-concave valve (upper 
curve) as compared with 71 % for the valve with a flat disc (lower 
curve). OP = operation; POST-OP == postoperative. Vertical 
bars == 70% confidence limit; * == p < 0.05; : == p < om. 
Two rows of numbers at bottom are patients at risk for convexo•
concave disc (top) and flat disc (bottom). 
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Figure 12. Functional improvement 18 months after operation in 
229 patients according to New York Heart Association (NYHA) 
functional classification. PRE-OP = preoperative; POST-OP = 
postoperative. 
Table 1. Clinical Characteristics of 238* Patients Undergoing 
Valve Replacement With the Monostrut Bjork-Shiley 
Valve Prosthesis 
AVR MVR 
(n = 159) (n = 79) 
Age (yr) 
Mean 62 59 
Range 6 to 78 2 to 72 
Sex (% male) 61 42 
NYHA functional class 
III and IV 57% 71% 
II 37% 29% 
Atrial fibrillation 12% 62% 
Heart volume (ml/cm2 BSA) 
Mean 535 610 
Range 380 to 1,280 400 to 1,400 
History of 
Congestive heart failure 24% 39% 
Syncope 25% 8% 
Angina pectoris 33% 22% 
Concomitant cardiac procedures 16% 10% 
Early mortality 3.9% 2.6% 
A VR = aortic valve replacement; BSA = body surface area; MVR 
mitral valve replacement; NYHA = New York Heart Association. 
*Thirty patients with double valve and tricuspid valve replacement were 
not included. 
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Table 2. Monostrut Valves Implanted in 268 Patients 
Location 
AVR 
RE-AVR 
MVR 
RE-MVR 
AVR + MVR 
TVR 
MVR + TVR 
Total 
No. of 
Patients 
155 
4 
78 
26 
3 
268 
A VR = aortic valve replacement; MVR = mitral valve replacement; 
RE = repeat; TVR = tricuspid valve replacement. 
Table 3. Linearized Complication Rates (% patient-year) After 
Monostrut Valve Implantation in 174 Patients Receiving 
Anticoagulant Therapy 
Isolated Mitral Isolated Aortic 
Valve Replacement Valve Replacement 
(n = 70) (n = 104) 
Valve thrombosis 0 0 
Embolism 2.6 0.6 
Transient ischemic attack 1.8 0 
Bleeding 0.8 1.8 
Table 4. Blood Studies 1 Year After Monostrut Valve 
Implantation in 125 Patients 
Hemoglobin (glliter) 
Reticulocytes (%) 
LDH (Ukat/liter) 
LDH = lactic dehydrogenase. 
Postoperative 
143 ± 13 
0.55 ± 0.04 
10.5 ± 3.2 
Normal 
120 to 170 
0.2 to 2.0 
4.0 to 8.0 
Table 5. Postoperative Transseptal Catheterization After 
Monostrut Implantation in 17 Patients 
Age (yr) 
Mean 
Range 
Sex (male/female) 
Valve size (mm) 
Gradient (mm Hg) 
Calculated area (cm2) 
66 ± 7 
55 to 75 
4/13 
21 (n = 12) 
11 ± 3.5 
1.4 ± 0.2 
23 (n = 5) 
9 ± 2.3 
2.0 ± 0.1 
were within normal values in every patient (Table 4). The 
slight hemolysis demonstrated by the slightly elevated serum 
lactic dehydrogenase value is, therefore, not of clinical 
significance. 
Hemodynamics. In 17 patients with a narrow aortic root, 
right and transseptalleft heart catheterization was performed 
to evaluate the size 21 and 23 mm monostrut aortic valve 
prostheses. Most of these patients were women; mean age 
was 66 years. The mean transprosthetic pressure difference 
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was 11 mm Hg in the 21 mm and 9 mm Hg in the 23 mm 
Bjork-Shiley mono strut valves. The corresponding effective 
valve areas determined according to the Godin formula were 
1.4 cm2 for the 21 mm valve and 2.0 cm2 for the 23 mm 
valve (Table 5). 
Conclusion 
During 16 years of experience, the Bjork-Shiley tilting 
disc valve has been improved stepwise into a mono strut 
version that includes all optimal features of a tilting disc. 
1) The thromboembolic complication rate has been de•
creased by the use of the convexo-concave disc. 2) There 
is an optimal hemodynamic performance at the 70° opening 
angle, diminishing turbulence and vortices formation. 3) 
There is increased durability because the mono strut is made 
from one piece without welds. This valve cannot be frac•
tured under extreme experimental conditions at a pressure 
of 1,250 mm Hg and never under peak physiologic conditions. 
Eight hundred sixty-four valves have been implanted at 
the Karolinska Hospital during a 3V2 year period. Among 
the first 268 patients, all followed up for more than 2 years, 
there was no mechanical valve failure or clinical hemolysis. 
The hemodynamics were excellent, even in patients with a 
narrow aortic root. No valve thrombosis was encountered. 
In patients receiving anticoagulant therapy, the thromboem•
bolic complication rate during the first 2 years was 2.6% 
per patient-year for valves in the mitral position and 0.6% 
JACC Vol. 6. No.5 
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for valves in the aortic position. This annual incidence rate 
will further decrease when more follow-up time is accu•
mulated. Functional improvement was excellent. 
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